AMD 470 MILLION FINES TO BE PAID BY BUSINESSES IN MEDICINES TRADE.
/PanARMENIAN.Net/
21.12.2009 17:36 GMT+04:00
/PanARMENIAN.Net/ In September-November of 2009 numerous publications
in Armenian media, complaints submitted to SCPEC and followed
monitoring revealed unjustified high prices for some drugs in the
Armenian market.
According to the experts of State Commission for the Protection
of Economic Competition of Armenia (SCPEC), the situation in the
market of cardiovascular, diabetes and anti-flu drugs was the result
of anticompetitive agreements. Among the violators "Vaga Farm",
"Argo Farm", "Aesculapius", "Amicus", "Thetis Farm", "NATALI PHARM",
"Alfafarm" and "Armfarmatsia" have to pay AMD 470 million.
According to the Chairman of the State Commission for the Protection
of Economic Competition of Armenia Davit Harutyunyan, to implement
monitoring of medicines SCPEC collaborated with several state bodies,
in particular Ministry of Health, State Committee on Revenue, Central
Bank. According to him, the increase in prices of some drugs was
conditioned by dram devaluation.
/PanARMENIAN.Net/
21.12.2009 17:36 GMT+04:00
/PanARMENIAN.Net/ In September-November of 2009 numerous publications
in Armenian media, complaints submitted to SCPEC and followed
monitoring revealed unjustified high prices for some drugs in the
Armenian market.
According to the experts of State Commission for the Protection
of Economic Competition of Armenia (SCPEC), the situation in the
market of cardiovascular, diabetes and anti-flu drugs was the result
of anticompetitive agreements. Among the violators "Vaga Farm",
"Argo Farm", "Aesculapius", "Amicus", "Thetis Farm", "NATALI PHARM",
"Alfafarm" and "Armfarmatsia" have to pay AMD 470 million.
According to the Chairman of the State Commission for the Protection
of Economic Competition of Armenia Davit Harutyunyan, to implement
monitoring of medicines SCPEC collaborated with several state bodies,
in particular Ministry of Health, State Committee on Revenue, Central
Bank. According to him, the increase in prices of some drugs was
conditioned by dram devaluation.